Genetics

I haven't written much about the President's Cancer Moonshot initiative recently and as much as I would like - perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in...

Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention.  In one of the pieces I mentioned...

Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...

I love headlines such as these. First it was "Pigeons to Replace Pathologists in Diagnosing Benign from Malignant Tumors" now it is actual computer algorithms that get it right more times than and more so than ordinary surgical pathologists!...

“This is good news in the fight against cancer. With the launch of this new national resource, anyone can freely access raw genomic and clinical data for 12,000 patients - with more records to follow. Increasing the pool of researchers who...

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended...